{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:36:20Z","timestamp":1777869380840,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00108-026-02108-2","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:50:45Z","timestamp":1776775845000},"page":"506-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunkomplex- und komplementvermittelte Glomerulonephritiden","Immune complex- and complement-mediated glomerulonephritides"],"prefix":"10.1007","volume":"67","author":[{"given":"Vega","family":"G\u00f6decke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"7","key":"2108_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","volume":"23","author":"HJ Anders","year":"2023","unstructured":"Anders\u00a0HJ, Kitching\u00a0AR, Leung\u00a0N, Romagnani\u00a0P (2023) Glomerulonephritis: immunopathogenesis and immunotherapy. Nat Rev Immunol 23(7):453\u2013471. https:\/\/doi.org\/10.1038\/s41577-022-00816-y","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2108_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema\u00a0IM, Wilhelmus\u00a0S, Alpers\u00a0CE et\u00a0al (2018) Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93(4):789\u2013796. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023","journal-title":"Kidney Int"},{"issue":"1","key":"2108_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.kint.2025.08.035","volume":"109","author":"A Benigni","year":"2026","unstructured":"Benigni\u00a0A, Daina\u00a0E, L\u00f6ffler-Wirth\u00a0H et\u00a0al (2026) Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy. Kidney Int 109(1):178\u2013195. https:\/\/doi.org\/10.1016\/j.kint.2025.08.035","journal-title":"Kidney Int"},{"issue":"3-4","key":"2108_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000169122","volume":"17","author":"JS Cameron","year":"1997","unstructured":"Cameron\u00a0JS, Hicks\u00a0J (1997) The introduction of renal biopsy into nephrology from 1901 to 1961: a paradigm of the forming of nephrology by technology. Am J Nephrol 17(3-4):347\u2013358. https:\/\/doi.org\/10.1159\/000169122","journal-title":"Am J Nephrol"},{"issue":"11","key":"2108_CR5","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/ndt\/gfab302","volume":"37","author":"F Caravaca-Font\u00e1n","year":"2022","unstructured":"Caravaca-Font\u00e1n\u00a0F, Lucientes\u00a0L, Serra\u00a0N et\u00a0al (2022) C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies. Nephrol Dial Transplant 37(11):2128\u20132137. https:\/\/doi.org\/10.1093\/ndt\/gfab302","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2108_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1681\/ASN.2019080851","volume":"31","author":"S Chauvet","year":"2020","unstructured":"Chauvet\u00a0S, Berthaud\u00a0R, Devriese\u00a0M et\u00a0al (2020) Anti-Factor B Antibodies and Acute Postinfectious GN in Children. J\u00a0Am Soc Nephrol 31(4):829\u2013840. https:\/\/doi.org\/10.1681\/ASN.2019080851","journal-title":"J Am Soc Nephrol"},{"key":"2108_CR7","unstructured":"Deutsche Gesellschaft f\u00fcr Nephrologie (DGfN) (2025) S3-Leitlinie: \u201cDiagnose und Therapie von Glomerulonephritiden (S3-GN)\u201d Auflage\/Version Datum: M\u00e4rz 2025, V01."},{"issue":"1","key":"2108_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10238-025-01646-7","volume":"25","author":"P Esposito","year":"2025","unstructured":"Esposito\u00a0P, Macci\u00f2\u00a0L, Cagnetta\u00a0A et\u00a0al (2025) Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies. Clin Exp Med 25(1):118\u2013118. https:\/\/doi.org\/10.1007\/s10238-025-01646-7","journal-title":"Clin Exp Med"},{"issue":"5","key":"2108_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.kint.2020.05.053","volume":"98","author":"F Fakhouri","year":"2020","unstructured":"Fakhouri\u00a0F, Le Quintrec\u00a0M, Fr\u00e9meaux-Bacchi\u00a0V (2020) Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties. Kidney Int 98(5):1135\u20131148. https:\/\/doi.org\/10.1016\/j.kint.2020.05.053","journal-title":"Kidney Int"},{"issue":"1","key":"2108_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ard.2025.09.007","volume":"85","author":"A Fanouriakis","year":"2026","unstructured":"Fanouriakis\u00a0A, Kostopoulou\u00a0M, Anders\u00a0HJ et\u00a0al (2026) EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update. Ann Rheum Dis 85(1):75\u201390. https:\/\/doi.org\/10.1016\/j.ard.2025.09.007","journal-title":"Ann Rheum Dis"},{"key":"2108_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2026.1747678","volume":"6","author":"EJ Filippone","year":"2026","unstructured":"Filippone\u00a0EJ, Farber\u00a0JL (2026) Primary membranoproliferative glomerulonephritis: natural history, pathogenesis, and treatment. Front Nephrol 6:1747678. https:\/\/doi.org\/10.3389\/fneph.2026.1747678","journal-title":"Front Nephrol"},{"issue":"15","key":"2108_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMoa2410965","volume":"392","author":"RA Furie","year":"2025","unstructured":"Furie\u00a0RA, Rovin\u00a0BH, Garg\u00a0JP et\u00a0al (2025) Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. N\u00a0Engl J Med 392(15):1471\u20131483. https:\/\/doi.org\/10.1056\/NEJMoa2410965","journal-title":"N Engl J Med"},{"key":"2108_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pcl.2018.08.005","volume":"66","author":"EAK Hunt","year":"2019","unstructured":"Hunt\u00a0EAK, Somers\u00a0MJG (2019) Infection-Related Glomerulonephritis. Pediatr Clin North Am 66:59","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"2108_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2023.151469","volume":"43","author":"A Iyengar","year":"2023","unstructured":"Iyengar\u00a0A, Kamath\u00a0N, Radhakrishnan\u00a0J, Estebanez\u00a0BT (2023) Infection-Related Glomerulonephritis in Children and Adults. Semin Nephrol 43(5):151469. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151469","journal-title":"Semin Nephrol"},{"issue":"1S","key":"2108_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group (2024) KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int 105(1S):S1\u2013S69. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002","journal-title":"Kidney Int"},{"issue":"5","key":"2108_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050712","volume":"12","author":"M Kovala","year":"2023","unstructured":"Kovala\u00a0M, Sepp\u00e4l\u00e4\u00a0M, R\u00e4is\u00e4nen-Sokolowski\u00a0A, Meri\u00a0S, Honkanen\u00a0E, Kaartinen\u00a0K (2023) Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy. Cells 12(5):712. https:\/\/doi.org\/10.3390\/cells12050712","journal-title":"Cells"},{"issue":"11","key":"2108_CR17","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2215\/CJN.01570219","volume":"14","author":"S Kudose","year":"2019","unstructured":"Kudose\u00a0S, Santoriello\u00a0D, Bomback\u00a0AS, Stokes\u00a0MB, D\u2019Agati\u00a0VD, Markowitz\u00a0GS (2019) Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis. Clin J Am Soc Nephrol 14(11):1605\u20131615. https:\/\/doi.org\/10.2215\/CJN.01570219","journal-title":"Clin J Am Soc Nephrol"},{"key":"2108_CR18","first-page":"144","volume-title":"The Cambridge Historical Dictionary of Disease","author":"DM Larson","year":"2003","unstructured":"Larson\u00a0DM (2003) Glomerulonephritis (Bright\u2019s Disease). In: Kiple\u00a0KF (ed) The Cambridge Historical Dictionary of Disease. Cambridge University Press, Cambridge, pp\u00a0144\u2013146"},{"issue":"6","key":"2108_CR19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2215\/CJN.11830720","volume":"16","author":"M Lemaire","year":"2021","unstructured":"Lemaire\u00a0M, Noone\u00a0D, Lapeyraque\u00a0AL, Licht\u00a0C, Fr\u00e9meaux-Bacchi\u00a0V (2021) Inherited Kidney Complement Diseases. Clin J Am Soc Nephrol 16(6):942\u2013956. https:\/\/doi.org\/10.2215\/CJN.11830720","journal-title":"Clin J Am Soc Nephrol"},{"key":"2108_CR20","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung\u00a0N, Bridoux\u00a0F, Hutchison\u00a0CA et\u00a0al (2012) Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120:4292","journal-title":"Blood"},{"issue":"11","key":"2108_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","volume":"20","author":"J Lichtnekert","year":"2024","unstructured":"Lichtnekert\u00a0J, Anders\u00a0HJ (2024) Lupus nephritis-related chronic kidney disease. Nat Rev Rheumatol 20(11):699\u2013711. https:\/\/doi.org\/10.1038\/s41584-024-01158-w","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2108_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/md.0b013e318161b0fc","volume":"87","author":"SH Nasr","year":"2008","unstructured":"Nasr\u00a0SH, Markowitz\u00a0GS, Stokes\u00a0MB, Said\u00a0SM, Valeri\u00a0AM, D\u2019Agati\u00a0VD (2008) Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore) 87(1):21\u201332. https:\/\/doi.org\/10.1097\/md.0b013e318161b0fc","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2108_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.semnephrol.2017.05.018","volume":"37","author":"M Noris","year":"2017","unstructured":"Noris\u00a0M, Remuzzi\u00a0G (2017) Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement. Semin Nephrol 37(5):447\u2013463. https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.018","journal-title":"Semin Nephrol"},{"issue":"2","key":"2108_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ndt\/gfad182","volume":"39","author":"M Noris","year":"2024","unstructured":"Noris\u00a0M, Remuzzi\u00a0G (2024) C3G and Ig-MPGN-treatment standard. Nephrol Dial Transplant 39(2):202\u2013214. https:\/\/doi.org\/10.1093\/ndt\/gfad182","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2108_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","volume":"84","author":"MC Pickering","year":"2013","unstructured":"Pickering\u00a0MC, D\u2019Agati\u00a0VD, Nester\u00a0CM et\u00a0al (2013) C3 glomerulopathy: consensus report. Kidney Int 84(6):1079\u20131089. https:\/\/doi.org\/10.1038\/ki.2013.377","journal-title":"Kidney Int"},{"key":"2108_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.670727","volume":"12","author":"R Piras","year":"2021","unstructured":"Piras\u00a0R, Breno\u00a0M, Valoti\u00a0E et\u00a0al (2021) CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis. Front Genet 12:670727. https:\/\/doi.org\/10.3389\/fgene.2021.670727","journal-title":"Front Genet"},{"issue":"11","key":"2108_CR27","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1093\/rheumatology\/keaf324","volume":"64","author":"C Poggi","year":"2025","unstructured":"Poggi\u00a0C, Hachulla\u00a0E, Karras\u00a0A et\u00a0al (2025) Prognosis of essential mixed cryoglobulinemia and connective tissue disease-related cryoglobulinemia after rituximab-induced remission. Rheumatology (Oxford) 64(11):5665\u20135672. https:\/\/doi.org\/10.1093\/rheumatology\/keaf324","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"2108_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","volume":"93","author":"A Ravindran","year":"2018","unstructured":"Ravindran\u00a0A, Fervenza\u00a0FC, Smith\u00a0RJH, De Vriese\u00a0AS, Sethi\u00a0S (2018) C3 Glomerulopathy: Ten Years\u2019 Experience at Mayo Clinic. Mayo Clin Proc 93(8):991\u20131008. https:\/\/doi.org\/10.1016\/j.mayocp.2018.05.019","journal-title":"Mayo Clin Proc"},{"key":"2108_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41581-019-0178-8","volume":"16","author":"AA Satoskar","year":"2020","unstructured":"Satoskar\u00a0AA, Parikh\u00a0SV, Nadasdy\u00a0T (2020) Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol 16:32","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"2108_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi\u00a0S, Fervenza\u00a0FC (2012) Membranoproliferative glomerulonephritis--a new look at an old entity. N\u00a0Engl J Med 366(12):1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMra1108178","journal-title":"N Engl J Med"},{"issue":"10335","key":"2108_CR31","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(22)00461-5","volume":"399","author":"S Sethi","year":"2022","unstructured":"Sethi\u00a0S, De Vriese\u00a0AS, Fervenza\u00a0FC (2022) Acute glomerulonephritis. Lancet 399(10335):1646\u20131663. https:\/\/doi.org\/10.1016\/S0140-6736(22)00461-5","journal-title":"Lancet"},{"issue":"2","key":"2108_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfy220","volume":"34","author":"S Sethi","year":"2019","unstructured":"Sethi\u00a0S, Fervenza\u00a0FC (2019) Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant 34(2):193\u2013199. https:\/\/doi.org\/10.1093\/ndt\/gfy220","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2108_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000013431","volume":"19","author":"P Stratta","year":"1999","unstructured":"Stratta\u00a0P, Canavese\u00a0C, Sandri\u00a0L et\u00a0al (1999) The concept of \u2019glomerulonephritis\u2019. The fascinating history of evolution and emergence of a specialist\u2019s nosology focus on Italy and Torino. Am J Nephrol 19(1):83\u201391. https:\/\/doi.org\/10.1159\/000013431","journal-title":"Am J Nephrol"},{"issue":"3","key":"2108_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","volume":"106","author":"M Vivarelli","year":"2024","unstructured":"Vivarelli\u00a0M, Barratt\u00a0J, Beck\u00a0LH Jr et\u00a0al (2024) The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 106(3):369\u2013391. https:\/\/doi.org\/10.1016\/j.kint.2024.05.015","journal-title":"Kidney Int"},{"issue":"2","key":"2108_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening\u00a0JJ, D\u2019Agati\u00a0VD, Schwartz\u00a0MM et\u00a0al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521\u2013530. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00443.x","journal-title":"Kidney Int"},{"issue":"4","key":"2108_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1681\/ASN.2015020114","volume":"27","author":"M Zaidan","year":"2016","unstructured":"Zaidan\u00a0M, Terrier\u00a0B, Pozdzik\u00a0A et\u00a0al (2016) Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. J\u00a0Am Soc Nephrol 27(4):1213\u20131224. https:\/\/doi.org\/10.1681\/ASN.2015020114","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2108_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1681\/ASN.2019050515","volume":"31","author":"PF Zipfel","year":"2020","unstructured":"Zipfel\u00a0PF, Wiech\u00a0T, Stea\u00a0ED, Skerka\u00a0C (2020) CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. J\u00a0Am Soc Nephrol 31(2):241\u2013256. https:\/\/doi.org\/10.1681\/ASN.2019050515","journal-title":"J Am Soc Nephrol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02108-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:38:07Z","timestamp":1777556287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2108"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02108-2","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.\u00a0G\u00f6decke: Berater- und Vortragst\u00e4tigkeiten: Astra Zeneca, Avanzanite, CSL Vifor Pharma, Novartis, Otsuka, Pfizer, Roche, Stadapharm; Forschungsf\u00f6rderung: Nieders\u00e4chsisches Ministerium f\u00fcr Wissenschaft und Kultur, Covid-19 Forschungsnetzwerk Niedersachsen, Bundesministerium f\u00fcr Gesundheit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}